Stock Ticker

  • Loading stock data...

Valeant Pharmaceuticals Intl Inc (NYSE:VRX) May Soon Announce Its Name Change, Sources Reveal

Valeant Pharmaceuticals Intl Inc (NYSE:VRX) in a number of its board meetings has had the matter about a name change delved into in a great way. This is still on the weighing balance and eyes are wide open to see what actually happens. The company’s chief executive Joseph Papa while making a statement outlined that […]

Eyegate Pharmaceuticals Inc (NASDAQ:EYEG) Licensing Deal Assessment And Breakdown

A major independent equity research firm focused on micro-cap and small-cap stocks, Traders News Source released a comprehensive assessment of Eyegate Pharmaceuticals Inc (NASDAQ:EYEG) licensing deal with major biotech Valeant Pharmaceuticals Intl Inc (NYSE:VRX) in full report. The company reported an exclusive licensing deal with Valeant on February 21, 2017. As per the terms of […]

Support Grows For Special Meeting Of Allergan, Inc. (NYSE:AGN) Shareholders

Boston, MA 09/12/2014 (wallstreetpr) – More investors in Allergan, Inc. (NYSE:AGN) continue to show their support for a special shareholder meeting, The Wall Street Journal stated in an article. The meeting is being sought by William Ackman’s Pershing Square Capital Management LP and Valeant Pharmaceuticals Intl Inc (NYSE:VRX). The two are seeking to take over […]

Are Investors of Allergan, Inc. (NYSE:AGN) Taken For a Ride By Hedge Fund? Are Hedge Funds In Collusion Course On Allergan, Inc. (NYSE:AGN) Shares?

Boston, MA 08/15/2014 (wallstreetpr) – Are head fund companies made a big money out of Allergan, Inc. (NYSE:AGN)’s potential bid to be sold or a takeover target company? If so, are the investors taken for a ride? If reports are to be believed, the regulator, Securities Exchange Commission or the SEC, seemed to have seized […]

Morgan Stanley (NYSE:MS) Pitched Its Defense Services To Allergan

Boston, MA 06/19/2014 (wallstreetpr) – Morgan Stanley (NYSE:MS) is the advice-giver to the Canada based pharmaceutical company, Valeant Pharmaceuticals Intl Inc (NYSE:VRX) in its $53 billion bid for Allergan, Inc. (NYSE:AGN). Morgan Stanley, the global financial service firm initially attempted to get appointed by Allergan. According to Allergan, Morgan Stanley is the unwanted bidder in […]

Allergan, Inc. (NYSE:AGN) Loses Latisse Eyelash Ruling; Rejects Valeant Pharmaceuticals Intl Inc (NYSE:VRX) Offer

Boston, MA 06/11/2014 (wallstreetpr) – Allergan, Inc. (NYSE:AGN), the Botox wrinkle therapy maker, lost a ruling in the appeals court which will cause generic versions of the company’s Latisse eyelash medicine enter the marketplace. Ruling Rejected Allergan, Inc. (NYSE:AGN) and Duke University owned two patents on its drug Latisse but as per the website posting, […]

Valeant Pharmaceuticals Intl Inc (NYSE:VRX) Raises Bid To $53 Billion To Buy Allergan, Inc. (NYSE:AGN)

Boston, MA 06/02/2014 (wallstreetpr) – Valeant Pharmaceuticals Intl Inc (NYSE:VRX) increased its offer to acquire Allergan, Inc. (NYSE:AGN) for the second time in the week. Second Raise In A Week The Canada based drug maker said on Friday that it is agreeable to offer $72 and in addition a part of its stock for each […]

Valeant Pharmaceuticals Intl Inc (NYSE:VRX) and its businesses

Boston, MA 09/26/2013 (wallstreetpr) – Wednesday’s trading  In Wednesday’s trading session, Valeant Pharmaceuticals Intl Inc (NYSE:VRX) stock dropped by 1.34%. The shares opened at a price of $103.64, climbed to an intraday high of $103.74 and headed to a close of $102.34. Approximately 0.852 million shares were traded on Wednesday and an average volume of 1.14 […]